Sorafenib and Letrozole, Anastrozole, or Exemestane in Treating Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Metastatic Breast Cancer
Clinical trial NCT00573755 · TERMINATED
Trial details
- NCT number
- NCT00573755
- Sponsor
- Mayo Clinic
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2013-04-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.